Case report: Nucleoside analogue-induced lactic acidosis in the third trimester of pregnancy [3]

AIDS

Volumn 17, Issue 2, 2003, Pages 272-273

  Mandelbrot, Laurent ^a   Kermarrec, Nathalie ^a   Marcollet, Anne ^a   Lafanechère, Aurélie ^a   Longuet, Pascale ^a   Chosidow, Denis ^a   Saada, Mathieu ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CARNITINE; CD4 ANTIGEN; DIDANOSINE; EFAVIRENZ; NUCLEOSIDE DERIVATIVE; RIBOFLAVIN; RITONAVIR; SAQUINAVIR; STAVUDINE; THIAMINE; VIRUS RNA;

ABDOMINAL PAIN; ADULT; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; HEMODIALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; LETTER; METABOLIC ACIDOSIS; MITOCHONDRION; MONOTHERAPY; PANCREATITIS; PRIORITY JOURNAL; RIBOFLAVIN DEFICIENCY; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; STEATOSIS; TERATOGENESIS; THIRD TRIMESTER PREGNANCY; TOXICITY; TREATMENT OUTCOME; VOMITING;

ACIDOSIS, LACTIC; ADULT; ANTI-HIV AGENTS; DIDANOSINE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STAVUDINE;

EID: 0037462704     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200301240-00023     Document Type: Letter

References (6)

1. Sarner L, Fakoya A. Case report: acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication. Sex Transm Infect 2002, 78:58-59.
2. Brinkman K. Management of hyperlactatemia: no need for routine lactate measurements. AIDS 2001, 15:795-797.
3. Sanchez DJ, Murphy MM, Bosch-Sabater J, Fernandez-Ballard J. Enzymatic evaluation of thiamin, riboflavin and piridoxine status of parturient mothers and their newborn infants in a Mediterranean area of Spain. Eur J Clin Nutr 1999, 53:27-38.
4. Bristol-Myers Squibb Company. Healthcare provider important drug warning letter. 5 January 2001.
5. Luzzati R, Del Bravo P, Di Perri G, Luzzani A, Concia E. Riboflavine and lactic acidosis. Lancet 1999, 353:901-902.
6. Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, et al. Persistant mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999, 354: 1084-1089.